from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3312c/-

LFCtreatmentdescriptionclass of inhibitor

-0.892

Amikacinug/mL Amikacintranslation

-0.106

Cap5-10ug/mL Capreomycintranslation

0.177

Rox10-50 ug/mL Roxithromycintranslation

-0.140

SM2-5 ug/mL Streptomycintranslation

0.573

Tet5-10 ug/mL Tetracyclinetranslation

-0.348

Rif0.2-5ug/mL Rifampicintranscription

0.473

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.413

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.775

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.901

CPZ10-50 ug/mL Chlorpromazinerespiration

0.719

Clofazimine10-13 ug/mL Clofaziminerespiration

0.297

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.376

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.609

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.175

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.087

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.242

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.244

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.053

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.892

KCN5-20 ug/mL Potassium cyaniderespiration

0.095

NaN30.2-2 mM Sodium aziderespiration

0.814

Nigericin50 uM Nigericinrespiration

0.673

TRC10-150 ug/mL Triclosanrespiration

1.672

TRZ10-25 ug/mL Thioridazinerespiration

-0.410

Valinomycin0.5-10 uM Valinomycinrespiration

0.260

ZnSO42 mM ZnSO4respiration

0.236

menadione6-10 ug/mL Menadionerespiration

0.132

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.637

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.617

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.563

NRP_1Non-replicating persistence stage 1dosRassociated

-0.546

Amp0.2mg/mL AmpicillincellWall

0.218

Cephalexin20-100 ug/mL CephalexincellWall

0.455

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.498

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.575

EMB10-20 ug/mL EthambutolcellWall

-0.360

Eta12-40 ug/mL EthionamidecellWall

-0.678

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.210

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.774

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.130

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.950

BZA0.12 mg/mL BenzamidearomaticAmides

0.065

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.528

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.012

H2O24 mM hydrogen peroxideDNAdamaging

-0.539

Levo10 ug/mL LevofloxacinDNAdamaging

-0.474

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.014

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.308

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.478

UVUV-irradiationDNAdamaging

1.028

ARP41-4 ug/mL Antitubercular compound ARP4?

-1.955

Antimycin12.5-50 ug/mL Antimycin A?

0.630

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.060

PA_110-50 ug/mL Antitubercular compound PA-1?

0.294

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.276

PA8240.2-2 ug/mL PA-824?

0.185

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.062

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.122

Verapamil50 uM Verapamil?

0.565

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.397

methoxatin10-20 ug/mL Methoxatin?